PubMed · 2026
UBT251, a novel triple GLP-1, GIP, and glucagon receptor agonist, in adults with type 2 diabetes: A multicenter, randomized phase 2 trial
Zhou Z, Shi X, Jiang S, et al. (2026). UBT251, a novel triple GLP-1, GIP, and glucagon receptor agonist, in adults with type 2 diabetes: A multicenter, randomized phase 2 trial. Cell Metab.
Cell Metab
Source: https://pubmed.ncbi.nlm.nih.gov/42933400/
Last reviewed . By the PeptIQ team.
This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.